Table 2.
Tumor responses 1–2 months after transcatheter arterial chemoembolization (TACE)
| TACE alone (n = 24) | TACE + TAI (n = 44) | P value | |
|---|---|---|---|
| Response | 0.89 | ||
| CR | 11 (45.8%) | 19 (43.2%) | |
| PR | 9 (37.5%) | 18 (40.9%) | |
| SD | 3 (12.5%) | 5 (11.4%) | |
| PD | 1 (4.2%) | 2 (4.5%) | |
| ORR (CR + PR) | 20 (83.3%) | 37 (84.1%) | 0.94 |
| DCR (CR + PR + SD) | 23 (95.8%) | 42 (95.5%) | 0.94 |
CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD, stable disease; TACE, transcatheter arterial chemoembolization.